In the past week, CRH stock has gone down by -2.87%, with a monthly decline of -7.48% and a quarterly plunge of -7.01%. The volatility ratio for the week is 2.10%, and the volatility levels for the last 30 days are 1.42% for CRH Plc The simple moving average for the past 20 days is -2.61% for CRH’s stock, with a -4.49% simple moving average for the past 200 days.
Is It Worth Investing in CRH Plc (NYSE: CRH) Right Now?
The price-to-earnings ratio for CRH Plc (NYSE: CRH) is above average at 19.15x. The 36-month beta value for CRH is also noteworthy at 1.22. There are mixed opinions on the stock, with 14 analysts rating it as a “buy,” 5 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
The public float for CRH is 674.60M, and at present, short sellers hold a 1.62% of that float. The average trading volume of CRH on June 17, 2025 was 6.67M shares.
CRH) stock’s latest price update
CRH Plc (NYSE: CRH) has seen a rise in its stock price by 0.52 in relation to its previous close of 90.04. However, the company has experienced a -2.87% decline in its stock price over the last five trading sessions. businesswire.com reported 2025-06-10 that ATLANTA & CHICAGO–(BUSINESS WIRE)–CRH Medical Corporation (“CRH”), a leading provider of products and services for gastrointestinal (GI) providers and a wholly owned subsidiary of WELL Health Technologies Corp. (“WELL”), has announced a strategic partnership with WovenX Health (“WovenX”), a leader in integrated virtual specialty care. Together, they aim to deliver integrated, next-generation GI practice solutions designed to resolve persistent challenges surrounding patient access and operati.
Analysts’ Opinion of CRH
Many brokerage firms have already submitted their reports for CRH stocks, with Bernstein repeating the rating for CRH by listing it as a “Outperform.” The predicted price for CRH in the upcoming period, according to Bernstein is $115 based on the research report published on May 13, 2025 of the current year 2025.
HSBC Securities, on the other hand, stated in their research note that they expect to see CRH reach a price target of $116. The rating they have provided for CRH stocks is “Buy” according to the report published on November 11th, 2024.
Barclays gave a rating of “Overweight” to CRH, setting the target price at $110 in the report published on October 29th of the previous year.
CRH Trading at -1.19% from the 50-Day Moving Average
After a stumble in the market that brought CRH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.44% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CRH starting from ORiordain Padraig, who purchase 1,492 shares at the price of $99.16 back on May 13 ’25. After this action, ORiordain Padraig now owns 1,492 shares of CRH Plc, valued at $147,941 using the latest closing price.
Mintern Denis James, the Chief Executive Officer of CRH Plc, sale 4,097 shares at $102.93 during a trade that took place back on Mar 03 ’25, which means that Mintern Denis James is holding 35,757 shares at $421,693 based on the most recent closing price.
Stock Fundamentals for CRH
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.36 for the gross margin
The net margin for CRH Plc stands at 0.09. The total capital return value is set at 0.11. Equity return is now at value 15.78, with 6.61 for asset returns.
Based on CRH Plc (CRH), the company’s capital structure generated 0.45 points at debt to capital in total, while cash flow to debt ratio is standing at 0.3. The debt to equity ratio resting at 0.8. The interest coverage ratio of the stock is 7.45.
Currently, EBITDA for the company is 7.12 billion with net debt to EBITDA at 1.95. When we switch over and look at the enterprise to sales, we see a ratio of 2.09. The receivables turnover for the company is 6.96for trailing twelve months and the total asset turnover is 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.63.
Conclusion
In summary, CRH Plc (CRH) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
